OKYO Pharma Limited

US$1.43As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OKYOHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (16.27%)
Div yield —
ROE (263.78%)
Biotechnology
Beta (5Y) (0.14)
PE TTM —
TSR TTM (47.81%)
Mkt cap US$75.05M
ROIC (156.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.43
0.29%
(48.19%)
Hold 6|12|4|3|5
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.02
0.02
0.02
0.02
5.92%
7.22%
8.47%
11.05%
Revenue$M
4.626
4.770
4.744
4.886
3.40%
6.30%
4.27%
10.24%
Peers (US$75.05M)
Cap (US$)
PE
62.15M
—
75.03M
—
Capital
TTM
5Y
10Y
Leveragex
1.403
0.020
0.015
EBIT/Intx
1.589
0.656
0.650
Own earn%
22.97
(23.26)
(20.03)
Sh yield%
32.33
34.90
32.00
Owners
Insiders/Inst%
13.53
76.92
Short interest%
2.94
SBC / revenue%
0.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
18–24
$1 testx
—
Incr. ROIC%
10